Prime Minister, Justin Trudeau announced that COVID-19 vaccine developer Moderna will build a state-of-the-art manufacturing facility in Quebec to deliver made-in-Canada vaccines. When completed, this new facility will be able to produce up to 100 million mRNA vaccine doses annually. It will also create hundreds of good jobs.
Construction is set to start this year and the facility is expected to be operational in 2024 at the earliest, subject to planning and regulatory approvals. In addition to COVID-19 vaccines, the facility is expected to be able to produce vaccines for other respiratory diseases, such as influenza – pending their ongoing development by Moderna and approval by Health Canada.
Strengthening our biomanufacturing and life sciences sector across the country will help re-establish Canada’s domestic vaccine manufacturing capability, bring Canadian innovation to the front lines of tomorrow’s health solutions, and ensure we are better prepared for future health crises – all while growing the economy and creating good jobs.
“COVID-19 vaccines saved lives and got Canadians back to doing the things they love.
Today’s announcement means that Canadian workers and Canadian innovation will play a key role in keeping our communities safe now and in the future. It also means hundreds of new, well-paying jobs as we recover from this pandemic and build a better future for everyone.” – Justin Trudeau, Prime Minister of Canada
“Today’s announcement is yet another example of our promise to Canadians to have their back throughout this pandemic and beyond. From the outset, we took short-term strategic actions with a long-term vision to ensure that Canada is well prepared for future pandemics while also strengthening our economy and creating good jobs for Canadians. Moderna establishing their operations here in Canada is a testimony to that vision and to Canada’s attractiveness as a place to invest and to innovate.” – François-Philippe Champagne, Minister of Innovation, Science and Industry
“One of our government’s top priorities is to protect the health and safety of people in Canada. Moderna’s new facility will strengthen domestic health security and pandemic preparedness through timely access to innovative, cutting-edge vaccines that help us save lives. Moderna’s presence will also further establish Canada as a global leader in mRNA technology, leading a new era of domestic health innovation.” – Jean-Yves Duclos, Minister of Health